Tien Liang BioTech Balance Sheet Health
Financial Health criteria checks 6/6
Tien Liang BioTech has a total shareholder equity of NT$493.0M and total debt of NT$70.0M, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are NT$654.0M and NT$161.1M respectively. Tien Liang BioTech's EBIT is NT$18.9M making its interest coverage ratio 12.7. It has cash and short-term investments of NT$142.2M.
Key information
14.2%
Debt to equity ratio
NT$70.00m
Debt
| Interest coverage ratio | 12.7x |
| Cash | NT$142.22m |
| Equity | NT$492.98m |
| Total liabilities | NT$161.05m |
| Total assets | NT$654.04m |
Financial Position Analysis
Short Term Liabilities: 4127's short term assets (NT$309.0M) exceed its short term liabilities (NT$144.8M).
Long Term Liabilities: 4127's short term assets (NT$309.0M) exceed its long term liabilities (NT$16.2M).
Debt to Equity History and Analysis
Debt Level: 4127 has more cash than its total debt.
Reducing Debt: 4127's debt to equity ratio has reduced from 36% to 14.2% over the past 5 years.
Debt Coverage: 4127's debt is well covered by operating cash flow (99.5%).
Interest Coverage: 4127's interest payments on its debt are well covered by EBIT (12.7x coverage).